invited speakers to many conferences to talk on many topics including:
"Selecting and Evaluating Efficacy Endpoints for Lung Cancer Trials: What the Investigator and Clinician Should Know About the Statistics," Satellite Symposium on Lung Cancer Efficacy Endpoints, 13th World Conference on Lung Cancer, San Francisco, CA, 8/2/2009
"Adaptive designs based on biomarkers," 13th World Conference on Lung Cancer, San Francisco, CA, 8/4/2009
"Novel Designs in Phase II Studies," AACR Cancer Biostatistics Workshop, Sonoma, CA, 7/14/2009
"Biomarker Based Adaptive Designs for Targeted Agent Development - A Step Toward Personalized Medicine," Biostatistics Workshop in Cancer Research, University of Toronto, Toronto, Canada, 7/25/2009
"Bayesian Adaptive Designs for Targeted Therapy Development for Cancer and Beyond," University of Pennsylvania Annual Conference on Statistical Issues in Clinical Trials: Statistical Issues in Targeted Therapies, Philadelphia, 4/29/2009
"Adaptive designs for speeding up drug discovery," 100th Annual Meeting, American Association for Cancer Research (AACR), Denver, CO, 4/18/2009
Key publications:
Xian Zhou DD, Suyu Liu DD, Kim ES, Herbst RS, Lee JJ. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials 5(3):181-93, 2008.
Xian Zhou DD, Suyu Liu DD, Kim ES, Herbst RS, Lee JJ. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials 5(3):181-93, 2008.
Xian Zhou DD, Suyu Liu DD, Kim ES, Herbst RS, Lee JJ. Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials 5(3):181-93, 2008.
|